Sunandana Chandra

Hematology | Oncology

675 N St Clair St Ste 21-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Correction: Multilayer pyramid pooling self-attention for landslide detection using vision transformers.

Correction: Multilayer pyramid pooling self-attention for landslide detection using vision transformers.

Journal: Scientific reports

Published: July 23, 2026

Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma.

Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma.

Journal: JAMA dermatology

Published: July 08, 2026

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

Journal: JCO oncology practice

Published: June 23, 2026

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: June 15, 2026

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

TIL cell therapy in HIV positive patient with metastatic melanoma: case report.

TIL cell therapy in HIV positive patient with metastatic melanoma: case report.

Journal: Frontiers in oncology

Published: February 26, 2026

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Journal: Cancers

Published: November 27, 2025

Response to Gao and Chen, "Comments on Akaike et al's 'Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management'".

Response to Gao and Chen, "Comments on Akaike et al's 'Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management'".

Journal: Journal of the American Academy of Dermatology

Published: November 24, 2025

Contemporary Management of Merkel Cell Carcinoma.

Contemporary Management of Merkel Cell Carcinoma.

Journal: Hematology/oncology clinics of North America

Published: November 12, 2025

HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors.

HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors.

Journal: Future oncology (London, England)

Published: October 15, 2025

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.

Journal: Nature medicine

Published: September 12, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026